Edaravone

Drugs of the Future

Volumn 21, Issue 10, 1996, Pages 1014-1016

  Graul, A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT; NORPHENAZONE; SCAVENGER; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; DRUG SYNTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SHORT SURVEY;

EID: 0029854117     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.10.376470     Document Type: Short Survey

References (16)

1. Nishi, H., Watanabe, T., Yuki, S., Morinaka, Y., Iseki, K., Sakurai, H. (Mitsubishi Chemical Corp.). Prophylactic and therapeutic agent for circulatory disorders. EP 208874, JP 87108814, US 4857542.
2. Granger, D.N., Rutili, G., McCord, J.M. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981, 81: 22-9.
3. Rice-Evans, C.A., Diplock, A.T. Current status of antioxidant therapy. Free Radical Biol Med 1993, 15: 77-96.
4. Gulkley, G.K. Free radicals and other reactive oxygen metabolites: Clinical relevance and the therapeutic efficacy of antioxidant therapy. Surgery 1993, 113: 479-83.
5. Watanabe, T., Egawa, M. Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 1994, 271(3): 1624-9.
6. Watanabe, T., Morita, I., Nishi, H., Murota, S.-I. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostagland Leuk Essent Fatty Acids 1988, 33(1): 81-7.
7. Ochi, H., Morita, I., Murota, S.-I. Mechanism for endothelial cell injury induced by 15-hyperperoxyeicosatetraenoic acid, an arachidonate lipoxygenase product. Biochim Biophys Acta 1992, 1136: 247-52.
8. Watanabe, T., Yuki, S., Egawa, M., Nishi, H. Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994, 268(3): 1597-604.
9. Kuwahara, T., Watanabe, K., Watanabe, K., Yamamoto, Y. 3-Methyl-1-phenyl-2-pyrazolin-5-one as antioxidant. VIII Bienn Meet Int Soc Free Radical Res (October 1-5, Barcelona) 1996, 89.
10. Oishi, R., Itoh, Y., Nishibori, M., Watanabe, T., Nishi, H., Saeki, K. Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain. Stroke 1989, 20(11): 1557-64.
11. Abe, K., Yuki, S., Kogure, K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988, 19(4): 480-5.
12. Nishi, H., Watanabe, T., Sakurai, H., Yuki, S., Ishibashi, A. Effect of MCI-186 on brain edema in rats. Stroke 1989, 20(9): 1236-40.
13. Minhaz, U., Tanaka, M., Tsukamoto, H., Watanabe, K., Koide, S., Shohtsu, A., Nakazawa, H. Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. Free Radical Res 1996, 24(5): 361-7.
14. Yanagisawa, A., Fujita, H., Matsukura, T., Miyagawa. M., Ishikawa, K., Murota, S.-I. Cardioprotective effect of MCI-186 during acute ischemia-reperfusion injury in rats. Circulation 1989, 80(4, Suppl. 2): Abst 0971.
15. Takeo, M. The effects of MCI-186 for ischemic-reperfusion injury during cardiopulmonary bypass. Okayama Igakkai Zasshi 1993, 105(1/2): 217-26.
16. Mitsubishi Chemicals' pharmaceutical R&D and marketing plans. Kagaku Kogyo Nippo 1995, June 19.